206 related articles for article (PubMed ID: 19438226)
1. Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273.
Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
J Med Chem; 2009 Jul; 52(13):4063-7. PubMed ID: 19438226
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
[TBL] [Abstract][Full Text] [Related]
5. Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis.
Maresca A; Carta F; Vullo D; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):407-11. PubMed ID: 22145736
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
[TBL] [Abstract][Full Text] [Related]
7. 3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors.
Güzel O; Innocenti A; Vullo D; Scozzafava A; Supuran CT
Curr Pharm Des; 2010; 16(29):3317-26. PubMed ID: 20819062
[TBL] [Abstract][Full Text] [Related]
8. Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2011 Aug; 19(16):5023-30. PubMed ID: 21757360
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides.
Pacchiano F; Carta F; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2011 Jan; 21(1):102-5. PubMed ID: 21145236
[TBL] [Abstract][Full Text] [Related]
10. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis.
Maresca A; Scozzafava A; Vullo D; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):384-7. PubMed ID: 22214209
[TBL] [Abstract][Full Text] [Related]
11. The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets.
Nishimori I; Minakuchi T; Maresca A; Carta F; Scozzafava A; Supuran CT
Curr Pharm Des; 2010; 16(29):3300-9. PubMed ID: 20819064
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT
J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
Carta F; Maresca A; Covarrubias AS; Mowbray SL; Jones TA; Supuran CT
Bioorg Med Chem Lett; 2009 Dec; 19(23):6649-54. PubMed ID: 19846301
[TBL] [Abstract][Full Text] [Related]
15. Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis.
Ceruso M; Vullo D; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2014 Oct; 29(5):686-9. PubMed ID: 24156740
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules.
Singh S; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):449-55. PubMed ID: 23808803
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.
Poulsen SA; Wilkinson BL; Innocenti A; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2008 Aug; 18(16):4624-7. PubMed ID: 18644716
[TBL] [Abstract][Full Text] [Related]
18. A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
Joseph P; Ouahrani-Bettache S; Montero JL; Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Winum JY; Köhler S; Supuran CT
Bioorg Med Chem; 2011 Feb; 19(3):1172-8. PubMed ID: 21251841
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.
Maresca A; Vullo D; Scozzafava A; Manole G; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):392-6. PubMed ID: 22299588
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
